Delivery Order SPE2DB25D3201-SPE2DB25FNUGM
- Not listed
- The Defense Logistics Agency awarded a $35,490 delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of SKYRIZI 360 mg/2.4 mL on-body auto-injector units. This is a firm fixed price, non-competitive set-aside delivery order with an ultimate completion date of July 22, 2025, to be fulfilled from the vendor's operations in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $11,830.00 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 mL on-body 2.4 mL pharmaceutical product. The contract is a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and was awarded on July 18, 2025. This award represents a non-set-aside, competitively awarded contract and constitutes a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 ml on-body injectable medication. This firm fixed-price, non-set-aside delivery order is scheduled for completion by October 20, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop...
- The Defense Logistics Agency awarded a $11,830.00 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of SKYRIZI 360 mg/2.4 ml on-body injectable medication. This is a firm fixed price contract with an ultimate completion date of July 11, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for SKYRIZI 180 mg/1.2 ml on-body injectable medication, with a completion date of July 22, 2025. This is a firm fixed-price, non-set-aside contract awarded on June 30, 2025, with performance to be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a $23,660 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of SKYRIZI 360 mg/2.4 mL on-body injectors. This competitive, firm fixed-price delivery order is scheduled for completion by October 10, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $23,660 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 ml on-body injectable medication. The contract, which became effective on June 2, 2025, with an ultimate completion date of June 24, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). AmerisourceBergen will perform work from its Conshohocken, Pennsylvania facility, where the...
- The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 mL on-body injectable medication. This firm fixed-price contract, awarded on August 28, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery order will be fulfilled at the contractor's Conshohocken, Pennsylvania facility, with an ultimate completion date of September 19, 2025. No...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of SKYRIZI 360 MG/2.4 ML on-body injectable medication. This firm fixed-price delivery order, valued at $11,830.00, was competitively awarded without set-aside provisions and is scheduled for completion by August 29, 2025. The contract represents a child order under...
- The Defense Logistics Agency awarded a delivery order valued at $12,604.63 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 ml on-body injectable medication. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of May 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The award represents a...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNUGMDelivery Order
The Defense Logistics Agency awarded a $11,830 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 ml on-body injectable medication, with performance at the contractor's Conshohocken, Pennsylvania facility. This non-set-aside competitive award was issued on June 27, 2025, with an ultimate completion date of July 21, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor, particularly for Defense Health Agency and military healthcare systems. The company maintains an extensive portfolio of federal contracts with DLA Medical Supply Chain, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This award for SKYRIZI, a biologic medication used for immunological conditions, exemplifies the contractor's role in supporting military medical readiness through rapid pharmaceutical delivery within condensed timelines.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 6/27/25 |